Ampicillin for neonatal group B streptococcal prophylaxis: How rapidly can bactericidal concentrations be achieved?
- 1 October 1996
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 175 (4) , 974-976
- https://doi.org/10.1016/s0002-9378(96)80035-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Group B streptococcus: the US controversyThe Lancet, 1995
- Pharmacokinetics of ampicillin and sulbactam in pregnancyAmerican Journal of Obstetrics and Gynecology, 1993
- Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxisAmerican Journal of Obstetrics and Gynecology, 1986
- Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. III. Interruption of Mother-to-Infant TransmissionThe Journal of Infectious Diseases, 1983
- Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivativesAntimicrobial Agents and Chemotherapy, 1982
- In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activityAntimicrobial Agents and Chemotherapy, 1978
- Antibiotic-killing kinetics of group B streptococciThe Journal of Pediatrics, 1976
- Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancyAmerican Journal of Obstetrics and Gynecology, 1966